About zPREDICTA
zPREDICTA is a company based in San Jose (United States) founded in 2014 was acquired by Predictive Oncology in December 2021.. zPREDICTA has raised $220 thousand across 2 funding rounds from investors including Predictive Oncology, Propel(x) and Y Combinator. The company has 3 employees as of December 31, 2022. zPREDICTA offers products and services including 3D Cell Culture Models and Tumor-Specific In Vitro Models. zPREDICTA operates in a competitive market with competitors including Yecuris, Xentech, Chengdu Zhongke Aoge Biotechnology, Sagres Discovery and Zebrafish Lab, among others.
- Headquarter San Jose, United States
- Employees 3 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Zpredicta Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$220 K (USD)
in 2 rounds
-
Latest Funding Round
$100 K (USD), Seed
Jun 01, 2016
-
Investors
Predictive Oncology
& 2 more
-
Employee Count
3
as on Dec 31, 2022
-
Acquired by
Predictive Oncology
(Dec 01, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of zPREDICTA
zPREDICTA offers a comprehensive portfolio of products and services, including 3D Cell Culture Models and Tumor-Specific In Vitro Models. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides 3D models for evaluating anticancer agents in human-like tissue.
Enables testing of drug responses in organ-specific disease environments.
Funding Insights of zPREDICTA
zPREDICTA has successfully raised a total of $220K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $100 thousand completed in June 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $100,000
-
First Round
First Round
(18 Aug 2015)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2016 | Amount | Seed - zPREDICTA | Valuation |
investors |
|
| Aug, 2015 | Amount | Seed - zPREDICTA | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in zPREDICTA
zPREDICTA has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Predictive Oncology, Propel(x) and Y Combinator. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are accelerated via funding and educational programs.
|
Founded Year | Domain | Location | |
|
Deep technology startups are funded via equity crowdfunding platform.
|
Founded Year | Domain | Location | |
|
AI-based platform for cancer diagnostics and precision medicine is utilized.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by zPREDICTA
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - zPREDICTA
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Zpredicta Comparisons
Competitors of zPREDICTA
zPREDICTA operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Yecuris, Xentech, Chengdu Zhongke Aoge Biotechnology, Sagres Discovery and Zebrafish Lab, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Humanized liver rodent models are developed for biology research.
|
|
| domain | founded_year | HQ Location |
Patient-derived xenograft models for preclinical oncology research are provided.
|
|
| domain | founded_year | HQ Location |
Xenotransplantation technology for human-compatible organs is developed.
|
|
| domain | founded_year | HQ Location |
Creates innovative mouse models to analyze genes causing cancer diseases.
|
|
| domain | founded_year | HQ Location |
Zebrafish assays are utilized for preclinical and environmental evaluations.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Zpredicta
Frequently Asked Questions about zPREDICTA
When was zPREDICTA founded?
zPREDICTA was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Where is zPREDICTA located?
zPREDICTA is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
Is zPREDICTA a funded company?
zPREDICTA is a funded company, having raised a total of $220K across 2 funding rounds to date. The company's 1st funding round was a Seed of $120K, raised on Aug 18, 2015.
How many employees does zPREDICTA have?
As of Dec 31, 2022, the latest employee count at zPREDICTA is 3.
What does zPREDICTA do?
Founded in 2014 and headquartered in San Jose, United States, tumor-specific in vitro 3D models are developed for applications in cancer drug screening. The proprietary PD-3D platform is utilized to replicate human in vivo conditions in assays. Reconstructed bone models under the rBone product line are offered for testing potential therapeutics in oncology. Operations focus on biotechnology services supporting pharmaceutical research and development.
Who are the top competitors of zPREDICTA?
zPREDICTA's top competitors include Yecuris, Chengdu Zhongke Aoge Biotechnology and Zebrafish Lab.
What products or services does zPREDICTA offer?
zPREDICTA offers 3D Cell Culture Models and Tumor-Specific In Vitro Models.
Who are zPREDICTA's investors?
zPREDICTA has 3 investors. Key investors include Predictive Oncology, Propel(x), and Y Combinator.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.